LAS-

CL:CLINICALASCONDES

Clínica Las Condes

Stock

Last Close

11,114.00

20/11 13:46

Market Cap

118.10B

Beta: -

Volume Today

15

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '21	Dec '22	Dec '23
net income	18.42B -	4.05B 78.03%	-3.40B 184.04%
depreciation and amortization	12.44B -	13.41B 7.86%	8.31B 38.05%
deferred income tax
stock based compensation
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items	6.75B -	31.75B 370.49%	8.68B 72.66%
net cash provided by operating activities	37.60B -	49.21B 30.88%	13.59B 72.39%
investments in property plant and equipment	-7.70B -	-12.01B 55.92%	-5.60B 53.38%
acquisitions net
purchases of investments
sales maturities of investments	5.48B -
other investing activites	5.48B -	-804M 114.66%	-623.67M 22.43%
net cash used for investing activites	-2.22B -	-12.81B 477.77%	-5.60B 56.31%
debt repayment	-14.96B -	-36.16B 141.69%	-16.94B 53.15%
common stock issued
common stock repurchased
dividends paid		-5.53B -	-1.21B 78.03%
other financing activites	-1.21B -	7.29B 700.35%	31.86B 336.83%
net cash used provided by financing activities	-17.05B -	-44.56B 161.34%	-22.70B 49.06%
effect of forex changes on cash
net change in cash	18.33B -	-8.16B 144.52%	-14.71B 80.19%
cash at beginning of period	9.72B -	28.05B 188.63%	19.89B 29.10%
cash at end of period	28.05B -	19.89B 29.10%	5.18B 73.95%
operating cash flow	37.60B -	49.21B 30.88%	13.59B 72.39%
capital expenditure	-7.70B -	-12.01B 55.92%	-5.60B 53.38%
free cash flow	29.90B -	37.20B 24.43%	7.99B 78.52%

All numbers in (except ratios and percentages)